Research, development, production and distribution of nutritional health supplements,
dermocosmetics, dietary foods for special medical purposes and medical devices
<a href="/events">We will be present </a>
<a href="/about-us/quality">Certified quality</a>

Amnol is committed to maintaining the quality of its products and manufacturing processes, ISO 9001 and ISO 22716 (GMP for cosmetic products) certifications, and by the compliance with the FDA code CFR 21 (GMP for food supplements). The company guarantees excellence in its nutritional health supplements, dermocosmetics and medical devices by means of scrupulous methods of control and state of the art instruments, thus safeguarding the well-being of end users.

<a href="/expert">Ask the expert</a>

Our experts are at your disposal for any enquiries you may have regarding Amnol's products and will respond to your requests for any further information or informative literature. Please contact them by email or call on our toll free number.

News from the world

News from the world

  • Challenges in advancing the laser fiber through th...
    CONCLUSIONS: Both obstruction and higher patients' BMI are the main obstacles during endovenous laser ablation and usually needs a...
  • The use of high venous ligation as an adjunct to e...
    CONCLUSION: The use of a hybrid approach in the management of great saphenous incompetence appears to offer no recurrence, re-inte...
  • Frequency of use of elastic compression stockings ...
    CONCLUSIONS: Although there is sufficient evidence of the effectiveness of elastic compression stockings for treating chronic veno...
  • Seeking consensus amongst UK-based interventional ...
    CONCLUSION: This study achieved consensus statements on imaging diagnosis in women with suspected pelvic vein incompetence. These ...
  • Effects of compression therapy and venous surgery ...
    CONCLUSIONS: Compression increased tissue oxygenation and skin temperature to a greater extent than surgical intervention. This su...
  • Mechanochemical ablation for the treatment of supe...
    CONCLUSIONS: Mechanochemical ablation is a feasible and effective treatment for superficial venous incompetence. When using consen...
  • Relevance of flexibility versus radial force in ri...
    CONCLUSION: Dedicated venous stents show good patency outcomes and clinical results. Tapering and bad alignment between connecting...
  • Deep venous thrombosis in the clinical course of p...
    CONCLUSIONS: Patients with symptomatic pulmonary embolism and concomitant DVT have heavier thrombotic burden in the pulmonary arte...
  • Significant differences in patients with a complet...
    CONCLUSION: Great saphenous vein patients have more and sooner symptoms than small saphenous vein patients. This study discusses i...
  • Toenail alterations in chronic venous disease pati...
    CONCLUSION: Onychomycosis accounted for 40% of all toenail alterations. Patients with chronic venous disease often have severe and...
Newsletter

Newsletter

Sign up to our newsletter to keep up-to-date about what's new at AMNOL.








AMNOL Chimica Biologica S.r.l.
Registered office, Administrative and Sales Offices: Corso della Vittoria 14, 28100 Novara
Tel: +39 0321 499199 - Email: info@amnol.net
Share Capital € 250,000 issued capital R.E.A. Novara 10937 VAT code 01228730030 Tax Code 04170400156



AMNOL Chimica Biologica and Euronational are companies of the WTB group (company subject to management and co-ordination activity pursuant to Art.2497 CC by WTB Holding S.p.A. - Milan)


Quality Management System ISO 9001, GMP COSMETICS ISO 22716 and compliance with GMP FOOD SUPPLEMENTS (FDA CFR 21-part 111) issued by Bureau Veritas Italia SpA

Copyright 2019 by Amnol Chimica Biologica